|
⚲
|
| Keyboard |
| Armen Shanafelt | |
|---|---|
| Firm | |
| Address | c/o Sutro Biopharma, Inc 310 Utah Avenue, Suite 150 South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Sutro Biopharma Inc | 021-314024 | Director | 85.4 M of 85.4 M |
||
| Symic Holdings LLC | 021-287542 | Director | 29.4 M of 29.4 M |
||
| Aileron Therapeutics Inc | 021-277814 | Director | 30.1 M of 40.0 M |
||
| Symic Holdings LLC | 021-252529 | Director | 25.3 M of 25.4 M |
||
| Aeglea Biotherapeutics Inc | 021-236481 | Director | 44.0 M of 44.0 M |
||
| Symic Holdings LLC | 021-231723 | Director | 17.7 M of 18.0 M |
||
| Aileron Therapeutics Inc | 021-227346 | Director | 19.8 M of 33.0 M |
||
| Aeglea Biotherapeutics Holdings LLC | 021-209533 | Director | 10.7 M of 11.0 M |
||
| Protagonist Therapeutics Inc | 021-197788 | Director | 7.0 M of 18.0 M |
||
| Hemaquest Pharmaceuticals Inc | 021-176133 | Director | 6.5 M of 16.0 M |
||
| Hemaquest Pharmaceuticals | 021-110234 | Director | 16.1 M of 16.1 M |
||